107 related articles for article (PubMed ID: 11337186)
41. Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.
Stein GE; Schooley S; Tyrrell KL; Citron DM; Goldstein EJ
Int J Antimicrob Agents; 2007 Jan; 29(1):39-43. PubMed ID: 17189093
[TBL] [Abstract][Full Text] [Related]
42. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens.
Odenholt-Tornqvist I; Löwdin E; Cars O
Antimicrob Agents Chemother; 1995 Jan; 39(1):221-6. PubMed ID: 7695310
[TBL] [Abstract][Full Text] [Related]
43. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
[TBL] [Abstract][Full Text] [Related]
44. Macrolide resistance among invasive Streptococcus pneumoniae isolates.
Hyde TB; Gay K; Stephens DS; Vugia DJ; Pass M; Johnson S; Barrett NL; Schaffner W; Cieslak PR; Maupin PS; Zell ER; Jorgensen JH; Facklam RR; Whitney CG;
JAMA; 2001 Oct; 286(15):1857-62. PubMed ID: 11597287
[TBL] [Abstract][Full Text] [Related]
45. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
[TBL] [Abstract][Full Text] [Related]
46. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary.
Zhanel GG; Johanson C; Laing N; Hisanaga T; Wierzbowski A; Hoban DJ
Antimicrob Agents Chemother; 2005 May; 49(5):1943-8. PubMed ID: 15855517
[TBL] [Abstract][Full Text] [Related]
47. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae.
Bergman KL; Olsen KM; Peddicord TE; Fey PD; Rupp ME
Antimicrob Agents Chemother; 1999 May; 43(5):1291-3. PubMed ID: 10223956
[TBL] [Abstract][Full Text] [Related]
49. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation.
Sevillano D; Alou L; Aguilar L; Echevarría O; Giménez MJ; Prieto J
J Antimicrob Chemother; 2006 Jun; 57(6):1128-33. PubMed ID: 16617063
[TBL] [Abstract][Full Text] [Related]
50. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
[TBL] [Abstract][Full Text] [Related]
51. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
Barry AL; Fuchs PC; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):767-9. PubMed ID: 9405952
[TBL] [Abstract][Full Text] [Related]
52. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
Esposito S; Noviello S; Ianniello F
J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
[TBL] [Abstract][Full Text] [Related]
53. Activity of a novel series of acylides active against community-acquired respiratory pathogens.
Pandya M; Chakrabarti A; Rathy S; Katoch R; Venkataraman R; Bhateja P; Mathur T; Kumar GR; Malhotra S; Rao M; Bhadauria T; Barman TK; Das B; Upadhyay D; Bhatnagar PK
Int J Antimicrob Agents; 2010 Aug; 36(2):169-74. PubMed ID: 20493666
[TBL] [Abstract][Full Text] [Related]
54. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.
Barry AL; Fuchs PC; Brown SD
J Antimicrob Chemother; 1997 Jul; 40(1):139-40. PubMed ID: 9249220
[No Abstract] [Full Text] [Related]
55. Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.
Bauernfeind A; Jungwirth R; Eberlein E
Infection; 1995; 23(5):316-21. PubMed ID: 8557398
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological considerations in the emergence of resistance.
Amsden GW
Int J Antimicrob Agents; 1999 Mar; 11 Suppl 1():S7-14; discussion S31-2. PubMed ID: 10204634
[TBL] [Abstract][Full Text] [Related]
57. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.
Malhotra-Kumar S; Lammens C; Coenen S; Van Herck K; Goossens H
Lancet; 2007 Feb; 369(9560):482-90. PubMed ID: 17292768
[TBL] [Abstract][Full Text] [Related]
58. Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin.
Tateda K; Ishii Y; Matsumoto T; Furuya N; Nagashima M; Matsunaga T; Ohno A; Miyazaki S; Yamaguchi K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2271-5. PubMed ID: 8891128
[TBL] [Abstract][Full Text] [Related]
59. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
Buxbaum A; Forsthuber S; Sauermann R; Gattringer R; Graninger W; Georgopoulos A;
Int J Antimicrob Agents; 2004 Oct; 24(4):397-400. PubMed ID: 15380268
[TBL] [Abstract][Full Text] [Related]
60. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
